Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “PK/PD”

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00916110
What this trial is testing

Study Of Single Dose Of ATN-103 Administered To Healthy Japanese Male Subjects

Who this might be right for
Healthy
Ablynx, a Sanofi company 72
Not applicableStudy completedNCT05413343
What this trial is testing

Clinical Study on Monitoring the Plasma Concentration of Ceftazidime-Avibactam in Critically Ill Patients

Who this might be right for
Severe SepsisCarbapenem Resistant Bacterial Infection
First Affiliated Hospital of Zhejiang University 33
Early research (Phase 1)Study completedNCT02623868
What this trial is testing

Study to Assess PK/PD Character, Safety/Tolerability of CKD-519 New Formulation in Healthy Male Subject.

Who this might be right for
Dyslipidemia
Chong Kun Dang Pharmaceutical 30
Early research (Phase 1)Study completedNCT01156779
What this trial is testing

Study to Evaluate Safety and PK/PD of DA-3091 in Healthy Male Subjects

Who this might be right for
Diabetes Mellitus
Dong-A Pharmaceutical Co., Ltd. 31
Testing effectiveness (Phase 2)WithdrawnNCT05703555
What this trial is testing

INTRUSION: Unraveling the INTRatUmoral PK/PD relatION for SAR408701

Who this might be right for
Metastatic Lung CancerMetastatic Breast CancerMetastatic Gastric Cancer
Erasmus Medical Center
Testing effectiveness (Phase 2)Study completedNCT02808585
What this trial is testing

Study to Assess the Safety, Tolerability and PK/PD After 4 Weekly SC Injections of PB1046 in Subjects With Stable HFrEF

Who this might be right for
Heart Failure
PhaseBio Pharmaceuticals Inc. 29
Early research (Phase 1)Study completedNCT01023321
What this trial is testing

First-in-Human Single Ascending and Multiple Dose of GLPG0555

Who this might be right for
Healthy
Lakefront Biotherapeutics NV 35
Early research (Phase 1)Study completedNCT00938678
What this trial is testing

Pharmacokinetic/Pharmacodynamic (PK/PD) Study Evaluating Pegfilgrastim Hospira Compared to Neulasta (Amgen) in Healthy Volunteers

Who this might be right for
Healthy
Hospira, now a wholly owned subsidiary of Pfizer 71
Post-approval studies (Phase 4)UnknownNCT05862402
What this trial is testing

Dose Optimization by Pharmacokinetic/Pharmacodynamic of Antibiotics to Improve Clinical Outcome of Carbapenem Resistant Klebsiella Pneumoniae Bloodstream Infections in Critically Ill Patients at Phramongkutklao Hospital

Who this might be right for
Carbapenem Resistant Klebsiella Pneumoniae
Phramongkutklao College of Medicine and Hospital 76
Large-scale testing (Phase 3)Study completedNCT05484401
What this trial is testing

Ibuprofen Liquid Capsules 2 x 200 mg Efficacy and PK/PD Study in Surgical Removal of Impacted Third Molars

Who this might be right for
Tooth, ImpactedTooth DiseasesStomatognathic Diseases
Reckitt Benckiser Healthcare (UK) Limited 294
Testing effectiveness (Phase 2)Active Not RecruitingNCT05387837
What this trial is testing

Safety, Tolerability and PK of Subcutaneous D-4517.2 in Subjects With Wet AMD or DME

Who this might be right for
Neovascular Age-related Macular DegenerationDiabetic Macular Edema
Ashvattha Therapeutics, Inc. 50
Early research (Phase 1)Study completedNCT06308861
What this trial is testing

Investigate Safety, Tolerability, PK/PK of J2H 1702 in Healthy Males

Who this might be right for
Non-alcoholic Steatohepatitis
J2H Biotech 100
Early research (Phase 1)Study completedNCT00868595
What this trial is testing

MTD Study of Vaccine BP-GMAX-CD1 Plus AP1903 to Treat Castrate Resistant Prostate Cancer

Who this might be right for
Castrate Resistant Prostate Cancer (CRPC)
Bellicum Pharmaceuticals 18
Early research (Phase 1)Study completedNCT00356642
What this trial is testing

Study Of Single And Ten Day Repeat Atopical Applications Of GW842470X Cream On The Skin Of Patients With Atopic Dermatitis

Who this might be right for
Dermatitis, Atopic
GlaxoSmithKline 45
Early research (Phase 1)Study completedNCT06160401
What this trial is testing

Evaluation of Safety, Tolerability, PK/PD, and Metabolism of Single-Dose Singletine(DC407) in Adults

Who this might be right for
Healthy Subjects
Guangzhou JOYO Pharma Co., Ltd 75
Testing effectiveness (Phase 2)Study completedNCT01681472
What this trial is testing

PK/PD Investigation of Modufolin (Arfolitixorin) in Plasma, Tumor and Adjacent Mucosa Adjacent Mucosa in Patients With Colon Cancer

Who this might be right for
Colonic Neoplasms
Isofol Medical AB 32
Early research (Phase 1)Study completedNCT02819726
What this trial is testing

PK, PD, Safety, and Efficacy of SAIT101 Versus MabThera® Versus Rituxan® in Patients With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Archigen Biotech Limited 294
Early research (Phase 1)Study completedNCT00908726
What this trial is testing

Population Pharmacokinetics/Pharmacodynamics (PK/PD) of Microemulsion Propofol in Healthy Volunteers

Who this might be right for
Healthy
Asan Medical Center 63
Early research (Phase 1)Looking for participantsNCT06086522
What this trial is testing

Trial to Evaluate Safety, PD & PK of IV Study Drug, QN-302, in Pts w/ Advanced or Metastatic Solid Tumors

Who this might be right for
Solid Tumor
Qualigen Theraputics, Inc. 54
Early research (Phase 1)Study completedNCT01119781
What this trial is testing

A Single-Dose, Pharmacokinetic/Pharmacodynamic (PK/PD), & Safety Study of BIIB017 in Participants With Renal Impairment & Healthy Volunteers

Who this might be right for
HealthyRenal Insufficiency
Biogen 35
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation